Literature DB >> 19690217

Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor.

Jingyan Han1, Guoquan Liu, Jasmina Profirovic, Jiaxin Niu, Tatyana Voyno-Yasenetskaya.   

Abstract

Protease-activated receptor 1 (PAR-1) mediates thrombin signaling in human endothelial cells. As a G-protein-coupled receptor, PAR-1 transmits thrombin signal through activation of the heterotrimeric G proteins, Gi, Gq, and G12/13. In this study, we demonstrated that zyxin, a LIM-domain-containing protein, is involved in thrombin-mediated actin cytoskeleton remodeling and serum response element (SRE)-dependent gene transcription. We determined that zyxin binds to the C-terminal domain of PAR-1, providing a possible mechanism of involvement of zyxin as a signal transducer in PAR-1 signaling. Data showing that disruption of PAR-1-zyxin interaction inhibited thrombin-induced stress fiber formation and SRE activation supports this hypothesis. Similarly, depletion of zyxin using siRNA inhibited thrombin-induced actin stress fiber formation and SRE-dependent gene transcription. In addition, depletion of zyxin resulted in delay of endothelial barrier restoration after thrombin treatment. Notably, down-regulation of zyxin did not affect thrombin-induced activation of RhoA or Gi, Gq, and G12/13 heterotrimeric G proteins, implicating a novel signaling pathway regulated by PAR-1 that is not mediated by G-proteins. The observation that zyxin targets VASP, a partner of zyxin in regulation of actin assembly and dynamics, to focal adhesions and along stress fibers on thrombin stimulation suggests that zyxin may participate in thrombin-induced cytoskeletal remodeling through recruitment of VASP. In summary, this study establishes a crucial role of zyxin in thrombin signaling in endothelial cells and provides evidence for a novel PAR-1 signaling pathway mediated by zyxin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690217      PMCID: PMC2812041          DOI: 10.1096/fj.09-131862

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Conformational activation of radixin by G13 protein alpha subunit.

Authors:  R Vaiskunaite; V Adarichev; H Furthmayr; T Kozasa; A Gudkov; T A Voyno-Yasenetskaya
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

2.  Analysis of the alpha-actinin/zyxin interaction.

Authors:  B Li; B Trueb
Journal:  J Biol Chem       Date:  2001-06-22       Impact factor: 5.157

3.  ActA and human zyxin harbour Arp2/3-independent actin-polymerization activity.

Authors:  J Fradelizi; V Noireaux; J Plastino; B Menichi; D Louvard; C Sykes; R M Golsteyn; E Friederich
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

4.  Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins.

Authors:  B Drees; E Friederich; J Fradelizi; D Louvard; M C Beckerle; R M Golsteyn
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

5.  Thrombin receptor signaling to cytoskeleton requires Hsp90.

Authors:  K S Pai; V B Mahajan; A Lau; D D Cunningham
Journal:  J Biol Chem       Date:  2001-06-18       Impact factor: 5.157

6.  Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton.

Authors:  V B Mahajan; K S Pai; A Lau; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.

Authors:  C B Martin; G M Mahon; M B Klinger; R J Kay; M Symons; C J Der; I P Whitehead
Journal:  Oncogene       Date:  2001-04-12       Impact factor: 9.867

8.  Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.

Authors:  P J O'Brien; N Prevost; M Molino; M K Hollinger; M J Woolkalis; D S Woulfe; L F Brass
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

9.  Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase C.

Authors:  B R Conklin; O Chabre; Y H Wong; A D Federman; H R Bourne
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

10.  Rho and Rac but not Cdc42 regulate endothelial cell permeability.

Authors:  B Wójciak-Stothard; S Potempa; T Eichholtz; A J Ridley
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

View more
  11 in total

Review 1.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 2.  Impedance-based cellular assays for regenerative medicine.

Authors:  W Gamal; H Wu; I Underwood; J Jia; S Smith; P O Bagnaninchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

3.  Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis.

Authors:  Alejandro Zimman; Sharon S Chen; Evangelia Komisopoulou; Bjoern Titz; Roxana Martínez-Pinna; Aarya Kafi; Judith A Berliner; Thomas G Graeber
Journal:  J Proteome Res       Date:  2010-06-04       Impact factor: 4.466

4.  Adherens junctions connect stress fibres between adjacent endothelial cells.

Authors:  Jaime Millán; Robert J Cain; Natalia Reglero-Real; Carolina Bigarella; Beatriz Marcos-Ramiro; Laura Fernández-Martín; Isabel Correas; Anne J Ridley
Journal:  BMC Biol       Date:  2010-02-02       Impact factor: 7.431

5.  A critical role for Lyn kinase in strengthening endothelial integrity and barrier function.

Authors:  Jingyan Han; Guoying Zhang; Emily J Welch; Ying Liang; Jian Fu; Stephen M Vogel; Clifford A Lowell; Xiaoping Du; David A Cheresh; Asrar B Malik; Zhenyu Li
Journal:  Blood       Date:  2013-10-09       Impact factor: 22.113

6.  Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.

Authors:  Xian-Mei Wen; Tao Luo; Yi Jiang; Li-Hong Wang; Ying Luo; Qian Chen; Kaidi Yang; Ye Yuan; Chunhua Luo; Xiang Zhang; Ze-Xuan Yan; Wen-Juan Fu; Yu-Huan Tan; Qin Niu; Jing-Fang Xiao; Lu Chen; Jiao Wang; Jia-Feng Huang; You-Hong Cui; Xia Zhang; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2020-01-16       Impact factor: 5.662

7.  Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction.

Authors:  Jing Peng; Fang He; Ciliu Zhang; Xiaolu Deng; Fei Yin
Journal:  J Neuroinflammation       Date:  2011-04-08       Impact factor: 8.322

8.  Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction.

Authors:  Jason J Rose; Deepak Voora; Derek D Cyr; Joseph E Lucas; Aimee K Zaas; Christopher W Woods; L Kristin Newby; William E Kraus; Geoffrey S Ginsburg
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

9.  Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity.

Authors:  Chunling Dong; Bo Li; Zhenyu Li; Sreerama Shetty; Jian Fu
Journal:  Oncotarget       Date:  2016-08-02

10.  Real-time quantitative monitoring of hiPSC-based model of macular degeneration on Electric Cell-substrate Impedance Sensing microelectrodes.

Authors:  W Gamal; S Borooah; S Smith; I Underwood; V Srsen; S Chandran; P O Bagnaninchi; B Dhillon
Journal:  Biosens Bioelectron       Date:  2015-04-25       Impact factor: 10.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.